Docket #: S93-077
A Novel Protein and Gene Expressed by Human T Cells and Monocytes: Alloreaction-Associated Antigen (ARAg)
Alloreaction-associated antigen (ARAg) is a novel member of the immunoglobulin superfamily. This invention's issued US patent claims composition of matter of ARAg polypeptides and nucleic acids encoding ARAg polypeptides.
Stanford research indicates ARAg may serve as an effector of immune response and a diagnostic antigen for antibody-based monitoring of immune disease.
Applications
- Drug Target
- Suppressing immune response using a monoclonal antibody against ARAg
- Monitoring immune diseases using MAb as a diagnostic
- Screening for ARAg receptors
U.S. Patent
U.S. Patent No. 5,646,251
Similar Technologies
-
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7 S83-007Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7
-
LSRE-1 Hybridoma - MEL-14 - ATCC# HB-132 S83-075LSRE-1 Hybridoma - MEL-14 - ATCC# HB-132
-
Multiplexed Ion Beam Imaging: High-resolution, High-sensitivity, Quantitative Tissue Imaging S13-106Multiplexed Ion Beam Imaging: High-resolution, High-sensitivity, Quantitative Tissue Imaging